Search Results Search Sort by RelevanceMost Recent In the Literature Jul 2004 The Physician's Role in Preventing Obesity Christian J. Krautkramer Virtual Mentor. 2004;6(7):312-315. doi: 10.1001/virtualmentor.2004.6.7.jdsc2-0407. State of the Art and Science Jul 2023 How Should We Approach Body Size Diversity in Clinical Trials? Dania Pagarkar, Erin Harrop, PhD, LICSW, and Lisa Erlanger, MD Despite concerns about clinical outcomes for patients with obesity, clinical trials report few data about such patients. AMA J Ethics. 2023;25(7):E517-527. doi: 10.1001/amajethics.2023.517. In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308.
In the Literature Jul 2004 The Physician's Role in Preventing Obesity Christian J. Krautkramer Virtual Mentor. 2004;6(7):312-315. doi: 10.1001/virtualmentor.2004.6.7.jdsc2-0407.
State of the Art and Science Jul 2023 How Should We Approach Body Size Diversity in Clinical Trials? Dania Pagarkar, Erin Harrop, PhD, LICSW, and Lisa Erlanger, MD Despite concerns about clinical outcomes for patients with obesity, clinical trials report few data about such patients. AMA J Ethics. 2023;25(7):E517-527. doi: 10.1001/amajethics.2023.517.
In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308.